Травматология и ортопедия России. 2011; : 57-61
ПРИМЕНЕНИЕ ОБОГАЩЕННОЙ ТРОМБОЦИТАМИ ПЛАЗМЫ В КУПИРОВАНИИ БОЛЕВОГО СИНДРОМА БОЛЬШОГО ВЕРТЕЛА
https://doi.org/10.21823/2311-2905-2011-0-2-57-61Аннотация
Представлены результаты сравнительного исследования применения обогащенной тромбоцитами плазмы (ОТП) и глюкокортикостероидов (ГКС) при локальной терапии болевого синдрома большого вертела (БСБВ). Всего обследовано 40 пациенток с БСБВ, которые были рандомизированы в группы по 20 человек. Состояние больных анализировали по шкале боли в течение дня (ВАШ) и индексу WOMAC. У 40 женщин с БСБВ в шестимесячном наблюдении показано, что локальное лечение инъекциями ОТП превосходит по эффективности терапию ГКС. Данные проведенного исследования позволяют расширить область применения ОТП и впервые рекомендовать проведение данного вида терапии при БСБВ. Локальная терапия ОТП отличается отсутствием нежелательных реакций и высокой эффективностью при БСБВ, превосходящей ГКС.
Список литературы
1. Кириллова, И.А. Сочетанное использование остеопластики и обогащенной тромбоцитами плазмы в травматологии и ортопедии / И.А. Кириллова, Н.Г. Фомичев, В.Т. Подорожная // Травматология и ортопедия России. – 2008. – № 3. – С. 63–67.
2. Bellamy, N. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patient with osteoarthritis of the hip or knee / N. Bellamy [et al.] // J. Rheumatol. – 1988. – Vol. 15. – P. 1833–1840.
3. Brinks, A. Effect of corticosteroid injection for trochanter pain syndrome: design of a randomised clinical trial in general practice. / A. Brinks [et al.] // BMC Musculoskelet. Disord. – 2007. – Vol. 8. – P. 95.
4. Cohen, S. Comparison of fluoroscopically guided and blind corticosteroid injections for greater trochanteric pain syndrome: multicentre randomised controlled trial. / S. Cohen [et al.] // BMJ. – 2009. – Vol. 338. – P. 1088.
5. Filardo, G. Use of platelet-rich plasma for the treatment of refractory jumper's knee. / G. Filardo [et al.] // Int. Orthop. – 2010. – Vol. 34, N 6. – P. 909 – 915.
6. Foster, T.E. Platelet-rich plasma: from basic science to clinical applications / T.E. Foster [et al.] // Am. J. Sports Med. – 2009. – Vol. 37. – P. 2259–2272.
7. Kon, E. Platelet-rich plasma: intra-articular knee injections produced favorable results on degenerative cartilage lesions / E. Kon [et al.] // Knee Surg. Sports Traumatol. Arthrosc.– 2010. – Vol. 18, N 4. – P. 472–479.
8. Lievense, A. Prognosis of trochanteric pain in primary care / A. Lievense [et al.] // Br. J. Gen. Pract. – 2005. – Vol. 55. – P. 199–204.
9. Riley, G. Tendinopathy – from basic science to treatment / G. Riley // Nature Clin. Practice Rheum. – 2008. – Vol. 4, N 2. – P. 82–89.
10. Sánchez, M. Platelet-rich therapies in the treatment of orthopaedic sport injuries / M. Sánchez [et al.] // Sports Med. – 2009. – Vol. 39, N 5. – P. 345–354.
11. Segal, N.A. Greater trochanteric pain syndrome: epidemiology and associated factors / N.A. Segal [et al.] // Arch. Phys. Med. Rehabil. – 2007. – Vol. 88. – P. 988–992.
12. Silva, F. Trochanteric bursitis: the myth of inflammation / F. Silva, T. Adams, J. Feinstein, R.A. Arroyo // J. Clin. Rheumatol. – 2008. – Vol. 14, N 2. – P. 82–86.
Traumatology and Orthopedics of Russia. 2011; : 57-61
APPLICATION OF PLATELET-RICH PLASMA IN REDUCTION OF GREATER TROCHANTERIC PAIN SYNDROME
https://doi.org/10.21823/2311-2905-2011-0-2-57-61Abstract
The results of a comparative study of platelet-rich plasma (PRP) and glucocorticosteroids (GCS) for local treatment of greater trochanteric pain syndrome (GTPS) are presented. 40 patients with GTPS were randomized into groups of 20 persons. The condition of patients was analyzed on a scale of pain during the day (VAS) and index WOMAC. 40 women with GTPS at six months of observation show that the local injections of PRP is superior to therapy with corticosteroids. The data of the study allow to expand the scope of the PRP and the first to recommend this therapy for GTPS. Local PRP therapy is distinguished by the absence of undesirable reactions, and high efficiency in GTPS exceeding the glucocorticosteroids.
References
1. Kirillova, I.A. Sochetannoe ispol'zovanie osteoplastiki i obogashchennoi trombotsitami plazmy v travmatologii i ortopedii / I.A. Kirillova, N.G. Fomichev, V.T. Podorozhnaya // Travmatologiya i ortopediya Rossii. – 2008. – № 3. – S. 63–67.
2. Bellamy, N. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patient with osteoarthritis of the hip or knee / N. Bellamy [et al.] // J. Rheumatol. – 1988. – Vol. 15. – P. 1833–1840.
3. Brinks, A. Effect of corticosteroid injection for trochanter pain syndrome: design of a randomised clinical trial in general practice. / A. Brinks [et al.] // BMC Musculoskelet. Disord. – 2007. – Vol. 8. – P. 95.
4. Cohen, S. Comparison of fluoroscopically guided and blind corticosteroid injections for greater trochanteric pain syndrome: multicentre randomised controlled trial. / S. Cohen [et al.] // BMJ. – 2009. – Vol. 338. – P. 1088.
5. Filardo, G. Use of platelet-rich plasma for the treatment of refractory jumper's knee. / G. Filardo [et al.] // Int. Orthop. – 2010. – Vol. 34, N 6. – P. 909 – 915.
6. Foster, T.E. Platelet-rich plasma: from basic science to clinical applications / T.E. Foster [et al.] // Am. J. Sports Med. – 2009. – Vol. 37. – P. 2259–2272.
7. Kon, E. Platelet-rich plasma: intra-articular knee injections produced favorable results on degenerative cartilage lesions / E. Kon [et al.] // Knee Surg. Sports Traumatol. Arthrosc.– 2010. – Vol. 18, N 4. – P. 472–479.
8. Lievense, A. Prognosis of trochanteric pain in primary care / A. Lievense [et al.] // Br. J. Gen. Pract. – 2005. – Vol. 55. – P. 199–204.
9. Riley, G. Tendinopathy – from basic science to treatment / G. Riley // Nature Clin. Practice Rheum. – 2008. – Vol. 4, N 2. – P. 82–89.
10. Sánchez, M. Platelet-rich therapies in the treatment of orthopaedic sport injuries / M. Sánchez [et al.] // Sports Med. – 2009. – Vol. 39, N 5. – P. 345–354.
11. Segal, N.A. Greater trochanteric pain syndrome: epidemiology and associated factors / N.A. Segal [et al.] // Arch. Phys. Med. Rehabil. – 2007. – Vol. 88. – P. 988–992.
12. Silva, F. Trochanteric bursitis: the myth of inflammation / F. Silva, T. Adams, J. Feinstein, R.A. Arroyo // J. Clin. Rheumatol. – 2008. – Vol. 14, N 2. – P. 82–86.
